Analysts think RDHL stock price could increase by 193797%
Aug 01, 2024, 6:25 AM
0.00%
What does RDHL do
RedHill Biopharma Ltd. specializes in developing treatments for gastrointestinal and infectious diseases, actively promoting drugs like Talicia for H. pylori and Aemcolo for travelers' diarrhea. The company's advanced clinical programs include RHB-204 for NTM disease, opaganib for multiple indications, RHB-107 for COVID-19, RHB-104 for Crohn's disease, and RHB-102 for chemotherapy-induced nausea.
3 analysts think RDHL stock price will increase by 193796.95%. The current median analyst target is $775.20 compared to a current stock price of $0.40. The lowest analysts target is $767.60 and the highest analyst target is $798.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
